Clal Biotechnology Industries Ltd (CBI) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.033x

Based on the latest financial reports, Clal Biotechnology Industries Ltd (CBI) has a cash flow conversion efficiency ratio of -0.033x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million ≈ $-2.85K USD) by net assets (ILA32.60 Million ≈ $87.40K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Clal Biotechnology Industries Ltd balance sheet quality to measure how much of total assets are equity-financed.

Clal Biotechnology Industries Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Clal Biotechnology Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Clal Biotechnology Industries Ltd to evaluate the quality of earnings relative to operating cash generation.

Clal Biotechnology Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clal Biotechnology Industries Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Elementis PLC LSE:ELM	0.069x
BIG Industries Bhd KLSE:7005	-0.080x
Oncozenge AB ST:ONCOZ	12.336x
Copaur Minerals Inc V:CPAU	-0.008x
Ironman International Ltd. V:IMI	-0.564x
Wong Engineering Corporation Bhd KLSE:7050	-0.012x
Rajshree Sugars & Chemicals Limited NSE:RAJSREESUG	-0.078x
Bermas SA RO:BRM	N/A

Annual Cash Flow Conversion Efficiency for Clal Biotechnology Industries Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Clal Biotechnology Industries Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA46.16 Million ≈ $123.77K	ILA-6.48 Million ≈ $-17.37K	-0.140x	-100.12%
2023-12-31	ILA121.41 Million ≈ $325.49K	ILA-8.51 Million ≈ $-22.82K	-0.070x	+82.79%
2022-12-31	ILA144.90 Million ≈ $388.46K	ILA-59.04 Million ≈ $-158.28K	-0.407x	-233.60%
2021-12-31	ILA338.37 Million ≈ $907.16K	ILA-41.33 Million ≈ $-110.80K	-0.122x	-88.87%
2020-12-31	ILA513.79 Million ≈ $1.38 Million	ILA-33.23 Million ≈ $-89.08K	-0.065x	-219.11%
2019-12-31	ILA497.85 Million ≈ $1.33 Million	ILA27.03 Million ≈ $72.46K	0.054x	+154.16%
2018-12-31	ILA867.62 Million ≈ $2.33 Million	ILA-86.98 Million ≈ $-233.19K	-0.100x	+11.36%
2017-12-31	ILA808.20 Million ≈ $2.17 Million	ILA-91.41 Million ≈ $-245.05K	-0.113x	+24.44%
2016-12-31	ILA752.50 Million ≈ $2.02 Million	ILA-112.63 Million ≈ $-301.97K	-0.150x	-11.24%
2015-12-31	ILA1.09 Billion ≈ $2.93 Million	ILA-147.00 Million ≈ $-394.10K	-0.135x	-46.12%
2014-12-31	ILA1.26 Billion ≈ $3.38 Million	ILA-115.95 Million ≈ $-310.86K	-0.092x	+14.64%
2013-12-31	ILA1.38 Billion ≈ $3.70 Million	ILA-148.98 Million ≈ $-399.40K	-0.108x	-85.31%
2012-12-31	ILA1.40 Billion ≈ $3.74 Million	ILA-81.22 Million ≈ $-217.75K	-0.058x	+37.01%
2011-12-31	ILA1.11 Billion ≈ $2.97 Million	ILA-102.45 Million ≈ $-274.67K	-0.092x	-1.22%
2010-12-31	ILA1.23 Billion ≈ $3.29 Million	ILA-111.93 Million ≈ $-300.07K	-0.091x	+17.70%
2009-12-31	ILA782.91 Million ≈ $2.10 Million	ILA-86.86 Million ≈ $-232.87K	-0.111x	+41.91%
2008-12-31	ILA274.45 Million ≈ $735.80K	ILA-52.41 Million ≈ $-140.52K	-0.191x	-25.63%
2007-12-31	ILA309.49 Million ≈ $829.73K	ILA-47.05 Million ≈ $-126.14K	-0.152x	+24.93%
2006-12-31	ILA116.28 Million ≈ $311.75K	ILA-23.55 Million ≈ $-63.13K	-0.203x	--

About Clal Biotechnology Industries Ltd

TA:CBI Israel Biotechnology

Market Cap

$11.31 Million

ILA4.22 Billion ILA

Market Cap Rank

#26755 Global

#384 in Israel

Share Price

ILA26.90

Change (1 day)

+2.67%

52-Week Range

ILA25.10 - ILA42.50

All Time High

ILA380.64